Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Avid Bioservices has advanced the expansion of its process development capabilities and labs, initiating demolition work at the site that will provide an additional 3,000 sq.-ft. of space.
read more
Thursday, October 07, 2021
Avid Bioservices a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, ...
read more
Avid Bioservices announced the appointment of Kerri McCullough Wood as Chief Commercial Officer.
read more
Avid Bioservices announced the appointment of Maria Ebro Andreasen as Chief People Officer.
The appointment comes as Avid continues to scale its operations to meet increasing customer demand and support long-term growth.
read more
Monday, November 10, 2025
Avid Bioservices announced the appointment of Dave Stewart as Chief Technology and Transformation Officer, a newly created role designed to advance the company's next phase of growth and evolution.
read more
Tuesday, January 11, 2022
Avid Bioservices, Inc. announced the official opening of the second downstream processing suite within the company’s existing Myford North facility.
read more
Thursday, October 14, 2021
Avid Bioservices, a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, ...
read more
Avid Bioservices announced the appointment of Timothy Compton as chief commercial officer.
read more
Avid Bioservices announced the appointment of Daniel Hart as chief financial officer.
read more
Friday, February 22, 2019
AveXis will create 200 jobs as it expands its manufacturing center in Durham County, North Carolina, Governor Roy Cooper has announced.
read more
AveXis has signed an agreement to purchase an advanced biologics therapy manufacturing campus in Colorado, further expanding its capacity as it prepares to launch Zolgensma®.
read more
Avet Pharmaceuticals is initiating a voluntary recall of the following lots of Tetracycline HCl Capsules USP, 250 mg and 500 mg, 100-count bottles.
read more
Thursday, January 21, 2016
Averica Discovery, an analytical development contract research organization (CRO) with specialized expertise in small molecule analysis and purification, has announced the appointment of Cynthia Berger, Ph.D., to the newly-created position of Vice ...
read more
Averica Discovery Services announced a new leadership team and the expansion into a larger facility to meet rising industry demand.
read more
Averica Discovery Services Inc., an analytical development Contract Research Organization (CRO) based in the Greater Boston area, and Dalton Pharma Services, a contract provider of integrated chemistry, drug development, and manufacturing services ...
read more